Skip to main content
Request a Sample

Ingredient collection

Liposomal Ingredients

Phospholipid-based ingredients for professional formulation work involving wetting, dispersion and content uniformity. Compare the published product information and request the current specification and supporting characterisation for the ingredient you are evaluating. No absorption or bioavailability claim is made.

Liposomal Ingredients — 7 ingredients

Showing 1–7 of 7 ingredients

Formulator’s buyer guide

Liposomal ingredients: a technical buyer’s guide

Liposomal powders should be selected by active loading, formulation fit and supporting evidence—not by the word liposomal alone. NexaGens supplies these ingredients for B2B formulation evaluation in food supplements and related applications.

The products in this collection are immediate, non-modified-release powders. Their purpose is formulation-specific, so buyers should compare the active, phospholipid delivery system, intended dosage form, processing conditions and controlled technical documentation before selection.

What should buyers verify before selecting a liposomal ingredient?

Buyers should verify the active and assay, phospholipid-based delivery system, release type, finished-product specification and evidence relevant to the intended formulation.

A liposomal label does not by itself establish structure, stability, dispersibility or finished-product performance. Request product-specific technical and quality documents, then confirm that the available evidence supports the intended dosage form and process.

Which formulation problem should the ingredient solve?

Start with the formulation requirement: delivery-system characterisation, dispersibility, protection from environmental stress or compatibility within a multi-ingredient formula.

Define the target market, dosage form, processing temperature, water activity, pH exposure, packaging and expected shelf life. These conditions determine which evidence is relevant and whether evaluation in the finished formulation is required.

Which liposomal powders are available?

The range includes liposomal powders of vitamin K2 MK-7, vitamin D3, curcumin, reduced glutathione, vitamin C, coenzyme Q10 and ferric pyrophosphate.

Use each product page to compare the published assay or loading, release type, ordering options and documentation pathway. Assess structural characterisation for the individual ingredient. For Vezicle™ Liposomal Ferric Pyrophosphate, request the current specification and supporting characterisation before relying on structural or performance claims.

What documentation should a B2B buyer request?

Request the current product-specific document set before commercial approval; where applicable, this may include a technical data sheet, approved specification and batch Certificate of Analysis.

Depending on the ingredient, qualification status, manufacturer and batch, also request the applicable composition, structural or performance, stability, microbiological, contaminant, allergen, GMO, storage and regulatory information. NexaGens confirms the current controlled documents for each enquiry; proprietary details are not published.

Discuss your formulation requirement

Tell us the active, dosage form, target market, processing conditions, target release or protection profile and expected volume. We can help identify suitable evaluation materials and confirm the available technical documents.

Document titles and availability are based on the supplied product workbook. Current controlled versions are provided on request and remain subject to technical and quality review.